Based on the current literature data, we hypothesized that overexpression of Gal3ST1 detected by immunohistochemistry in paraffin sections from patients with RCC reflects the malignant potential of RCC and negatively correlates with progression-free survival (PFS). Here, GAL3ST1 is linked to renal cell carcinoma.